期刊文献+

超声对中枢性性早熟女童的辅助诊断及药物治疗的疗效观察 被引量:5

Ultrasonography in diagnosing central precocious puberty of girls and clinical effect of drug therapy
下载PDF
导出
摘要 目的探讨超声检查在女童中枢性性早熟的辅助诊断及药物治疗的疗效评价。方法对28例中枢性性早熟患儿进行促性腺激素释放激素类似物(GnRHa)治疗,应用超声检测治疗前、治疗后3个月、治疗后6个月的子宫、卵巢大小及形态学变化,并与28例正常同龄女童的子宫、卵巢进行对比,予以促性腺激素释放激素(GnRH)激发试验采用化学发光法测定血清黄体生成素(LH)和卵泡刺激素(FSH)。结果中枢性性早熟女童治疗前的子宫容积、卵巢容积、卵泡直径、LH值、FSH值均大于正常女童,差异均有统计学意义(t分别=6.24、14.40、7.41、10.43、8.56,P均<0.05)。中枢性早熟女童治疗前、GnRHa治疗后3个月与6个月子宫、卵巢容积、卵泡直径、LH值、FSH值差异均有统计学意义(F分别=19.93、18.89、30.18、52.31、41.07,P均<0.05)。经LSD-t检验两两比较发现:与治疗前相比,治疗3个月和治疗6个月子宫容积、卵巢容积、卵泡直径、LH值、FSH值均下降,差异均有统计学意义(t分别=-8.32、-19.65、-7.89、-26.78、-9.61;-12.13、-9.31、-11.67、-30.15、-12.08,P均<0.05);治疗6个月与3个月相比,子宫容积、卵巢容积、卵泡直径减小,差异均有统计学意义(t分别=-5.32、-8.65、-6.89,P均<0.05);在GnRHa治疗6个月后子宫容积、卵巢容积与正常女童差异均有统计学意义(t分别=7.65、5.05,P均<0.05)。结论超声检查对中枢性性早熟女童的检出率高,对其治疗后的临床疗效的评价及疗效随访具有实用价值。 Objective To investigate the value of uhrasonography in diagnosing central precocious puberty of girls and curative effect of drug therapy. Methods Twenty eight cases of central precocious puberty were treated with gonadotropin releasing hormore analogues (GnRHa). The uterine and ovarian morphologie changes were monitored with ultrasound before treatment, 3 months and 6 months after treatment. Then compared with the noruaal control group. Serum luteinizing hor- mone (LH) and follicule-stimulating hormone (FSH) were measured by chemoluminescence. Results The uterine volumes, ovarian volumes, the size and the numbers of follieles,LH,FSH of the cases with central precocious puberty were significantly larger than those of the normal control group (t=6.24,14.40,7.41,10.43,8.56,P〈0.05) . The differeces of uterine and ovarian volumes, the size and the numbers of follicles,LH,FSH among before treatment, 3 months and 6 months after GnRHa treatment were statistically significant (F=19.93,18.89,30.18,52.31,41.07,P〈0.05). After 3 months and 6 months treatment, the uterine volumes, ovarian volumes, the size of follicles, LH, FSH of the cases with central precocious puberty were significantly smaller than that before treatment (t=-8.32, -19.65, -7.89, -26.78, -9.61 ; -12.13, -9.31, -11.67, -30.15,12.08 ,P〈0.05). Compared with 3 months treatment and after 6 months treatment, the uterine volumes, ovarian volumes and the size of follicles of the cases with central precocious puberty were significantly smaller(t=-5.32, -8.65,-6.89,P〈0.05). After 6 months GnRHa treatment , the uterine and ovarian volumes were statistically significant compared with those of the normal girls(t=7.65,5.05 ,P〈0.05). Conclusions Ultrasonography has great value on diagnosing central precocious puberty and evaluating its clinical effects.
出处 《全科医学临床与教育》 2013年第1期46-49,共4页 Clinical Education of General Practice
关键词 超声 中枢性性早熟 子宫容积 卵巢容积 卵泡 ultrasonography central precocious puberty uterine volume ovarian volume follicle
  • 相关文献

参考文献6

  • 1杜敏联.如何把握中枢性性早熟诊断和治疗中的核心问题[J].中华儿科杂志,2009,47(6):433-435. 被引量:8
  • 2De Vries L,Kauschansky A,Shohat M. Familial central precocious pubertysuggests autosomal dominant[J].Journal of Clinical Endocrinology and Metabolism,2004,(04):1794-1800.
  • 3Buzi F,Pilotta A,Dordoni D. Pelvic ultrasonography in normal girls and in girls with pubertal precocity[J].Acta Paediatrica,1998,(11):1138-1145.
  • 4Jensen AM,Brocks V,Holm K. Central precocious puberty in girls:Internal genitalia before,during,and after treatment with long-acting gonadot-ropin-releasing hormone analogues[J].Journal of Pediatrics,1998,(02):105-108.
  • 5杜敏联.中枢性(真性)性早熟诊治指南[J].中华儿科杂志,2007,45(6):426-427. 被引量:288
  • 6King LR,SiegeI MJ,Sobmn. Usefulness of ovarian volume and cysts in female is osexual precocious puberty[J].Journal of Ultrasound in Medicine,1993,(10):577-581.

二级参考文献24

  • 1马华梅,杜敏联,李燕虹,苏喆,陈红珊.促性腺激素释放激素类似物与生长激素联用治疗真性性早熟女孩的疗效评价[J].中华内分泌代谢杂志,2006,22(3):252-255. 被引量:23
  • 2杜敏联.中枢性(真性)性早熟诊治指南[J].中华儿科杂志,2007,45(6):426-427. 被引量:288
  • 3Herman-Giddens ME, Slora EJ, Wasserman RC, et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Ottice Settings network. Pediatrics, 1997,99:505-512.
  • 4Arrigo T, Cisternino M, Galluzzi F, et al. Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty. Eur J Endocrinol, 1999,141 : 140-144.
  • 5Carel JC, Chaussain JL Gonadotropin releasing hormone agonist treatment for central precocious puberty. Horm Res, 1999, 51 ( Suppl 3 ) : 64-69.
  • 6Pasquino AM, Pucarelli I, Accardn F, et al. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function. J Clin Endocrinol Metab, 2008,93 : 190- 195.
  • 7Eugster EA. Central precocious puberty: clinical management and consensus. Horm Res, 2008,70 Suppl 3:1.
  • 8Weise M, De-Levi S, Barnes KM, et al. Effects of estrogen on growth plate senescence and epiphyseal fusion. Proc Natl Acad Sci USA,2001,98 : 6871-6876.
  • 9Nilsson O, Baron J. Fundamental limits on longitudinal bone growth: growth plate senescence and epiphyseal fusion. Trends Endocrinol Metab,2004,15:370-374.
  • 10Loesch DZ, Hopper JL, Rogucka E, et al. Timing and genetic rapport between growth in skeletal maturity and height around puberty: similarities and differences between girls and boys. Am J Hum Genet, 1995,56:753-759.

共引文献291

同被引文献30

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部